Ben Mulhearn

@bath.ac.uk

Academic Clinical Fellow, Department of Life Sciences
University of Bath

EDUCATION

2005 - BSc Basic Clinical Sciences - St George's Hospital Medical School (University of London)
2008 - MBBS Medicine - St George's Hospital Medical School (University of London)
2011 - MSc Immunology with Immunogenetics - University of Manchester
2014 - MRCP (London)
2018 - PhD Immunology (medicine) - University of Manchester

RESEARCH INTERESTS

rheumatic diseases, immunology, precision medicine, cytometry, epidemiology, vasculitis, giant cell arteritis, VEXAS syndrome, rheumatoid arthritis, rheumatology

247

Scholar Citations

Scholar h-index

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

Prescribing habits before and after regulation change: a British perspective
B Mulhearn, M Bukhari
Rheumatology, keae713 2024

Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England
V Quick, M Abusalameh, S Ahmed, H Alkoky, M Bukhari, S Carter, ...
Rheumatology 63 (12), 3407-3414 2024

The Development and Validation of a Novel Training Infographic for the Physician Global Visual Analog Scale in Psoriatic Arthritis
S Gunawardana, PS Helliwell, MR Kok, M Vis, A Allard, A Akpabio, ...
The Journal of rheumatology 51 (11), 1084-1091 2024

OP0111 QUIESCENT HUMAN BLOOD MONOCYTE STATES ARE PRE-COMMITTED TO AN INFLAMMATORY SYNOVIAL TRANSCRIPTIONAL PROGRAM
E Amies, M Christofi, B Mulhearn, L Marshall, M Sutcliffe, K Hyrich, ...
Annals of the Rheumatic Diseases 83, 198-199 2024

POS0248 THE EVALUATION OF A NOVEL TRAINING INFOGRAPHIC FOR THE PHYSICIAN VISUAL ANALOGUE SCALE (VAS) IN PSORIATIC ARTHRITIS
S Gunawardana, PS Helliwell, MR Kok, M Vis, A Allard, A Akpabio, ...
Annals of the Rheumatic Diseases 83, 371-372 2024

OP0307 CELLULAR PROFILING OF SYNOVIAL FLUID IN INFLAMMATORY ARTHRITIS HIGHLIGHTS SHARED AND DISEASE-SPECIFIC CELL STATES WITH BIOLOGICAL AND DIAGNOSTIC RELEVANCE
M Christofi, S Valma, L Marshall, B Mulhearn, T Hussell, A Barton, D Rao, ...
Annals of the Rheumatic Diseases 83, 17 2024

Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.
H Alkoky, M Bukhari, S Carter, FL Coath, B Davidson, P Doddamani, ...
OUP 2023

Extent of Recording of 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a UK Healthcare Database
J Ellis, A McGrogan, N McHugh, B Mulhearn, E Korendowych, J Pauling, ...
ARTHRITIS & RHEUMATOLOGY 75, 258-259 2023

Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley
Heliyon 9 (7) 2023

POS0726 Rituximab versus cyclophosphamide for ANCA-associated vasculitis: a cost analysis
E Amor, B Mulhearn, W Tillett, C Cavill, S Tansley
Annals of the Rheumatic Diseases 82 (Suppl 1), 651-651 2023

Automated clustering reveals CD4⁺ T cell subset imbalances in rheumatoid arthritis
B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
Frontiers in Immunology 14, 1094872 2023

Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported
B Mulhearn
Annals of the rheumatic diseases 82 (5), e115 2023

Monocular Vision Loss in a Patient With Earache and Night Sweats
S Schimansky, G Cross, B Mulhearn
JAMA ophthalmology 141 (4), 396-397 2023

P208 PET-CT scanning of GCA patients: the additive role of opportunistic screening for cardiovascular disease in a high-risk population
B Mulhearn, J Ellis, R Foley, S Gunawardana, R Wickramarachchi, ...
Rheumatology 62 (Supplement_2), kead104. 249 2023

P110 Challenges of meeting NICE guidance for rheumatoid arthritis in the modern era: a service audit
H Cooney, J Ellis, B Mulhearn, A Allard
Rheumatology 62 (Supplement_2), kead104. 151 2023

E070 How well is the mental health of rheumatoid arthritis patients assessed in the routine rheumatology clinic?
H Cooney, J Ellis, B Mulhearn, A Allard
Rheumatology 62 (Supplement_2), kead104. 319 2023

CD4⁺ T cell subset imbalance in rheumatoid arthritis: a case-control study
B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
medRxiv, 2022.10. 20.22281307 2022

CD4⁺T cell subset imbalances in rheumatoid arthritis
B Mulhearn, L Marshall, M Sutcliffe, S Hannes, C Fonseka, T Hussell, ...
2022

The use of ELISA is comparable to immunoprecipitation in the detection of selected myositis-specific autoantibodies in a European population
A Loganathan, F McMorrow, H Lu, D Li, B Mulhearn, NJ McHugh, ...
Frontiers in Immunology 13, 975939 2022

Identification of Immune Cell Types in the Peripheral Blood of Rheumatoid Arthritis Patients Associated with Susceptibility and Response to Treatment
M Christofi, B Mulhearn, L Marshall, M Sutcliffe, D Plant, K Hyrich, ...
ARTHRITIS & RHEUMATOLOGY 74, 3447-3448 2022

MOST CITED SCHOLAR PUBLICATIONS

Indications for IVIG in rheumatic diseases
B Mulhearn, IN Bruce
Rheumatology 54 (3), 383-391 2015
Citations: 109

Autoantibodies in connective tissue disease
B Mulhearn, SL Tansley, NJ McHugh
Best Practice & Research Clinical Rheumatology 34 (1), 101462 2020
Citations: 28

Using the immunophenotype to predict response to biologic drugs in rheumatoid arthritis
B Mulhearn, A Barton, S Viatte
Journal of Personalized Medicine 9 (4), 46 2019
Citations: 25

A commercial anti-TIF1γ ELISA is superior to line and dot blot and should be considered as part of routine myositis-specific antibody testing
B Mulhearn, D Li, F McMorrow, H Lu, NJ McHugh, SL Tansley
Frontiers in Immunology 13, 804037 2022
Citations: 17

What rheumatologists need to know about innate lymphocytes
MA Exley, GC Tsokos, KHG Mills, D Elewaut, B Mulhearn
Nature Reviews Rheumatology 12 (11), 658-668 2016
Citations: 13

Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary
SL Barratt, HH Adamali, C Cotton, B Mulhearn, H Iftikhar, JD Pauling, ...
BMJ Open Respiratory Research 8 (1), e000829 2021
Citations: 10

Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley
Heliyon 9 (7) 2023
Citations: 8

Automated clustering reveals CD4⁺ T cell subset imbalances in rheumatoid arthritis
B Mulhearn, L Marshall, M Sutcliffe, SK Hannes, C Fonseka, T Hussell, ...
Frontiers in Immunology 14, 1094872 2023
Citations: 5

P290 Baseline monocyte count may help make a diagnosis of giant cell arteritis: results of routinely collected audit data from two centres
B Mulhearn, J Ellis, T Somoskeoy, A Bourn, S Knights, S Skeoch, ...
Rheumatology 61 (Supplement_1), keac133. 289 2022
Citations: 3

Rituximab fails to treat giant cell arteritis in a patient with ACPA-positive rheumatoid arthritis
B Mulhearn, E Cooper, S Knights
Rheumatology Advances in Practice 5 (1), rkab020 2021
Citations: 2

OP0281 EXCESS GIANT CELL ARTERITIS CASES ARE ASSOCIATED WITH PEAKS IN COVID-19 PREVALENCE
B Mulhearn, J Ellis, S Skeoch, J Pauling, S Tansley
Annals of the Rheumatic Diseases 80, 170 2021
Citations: 1